Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies.
Experimental vaccines, which independently achieve 48% and 68% reductions in malaria cases, can achieve 91% reduction when combined.
Presently, each vaccine is at a different stage of human trials, and there have not been efforts to combine them. However, a team led by Imperial College London have now tested the effectiveness when using the two types of vaccine together.
Reaching a potential 91% reduction in cases would have a huge impact on public health because the vaccines could be effective in areas where malaria is more prevalent.Dr Andrew Blagborough
The study, published today in the journal eLife, used genetically altered mouse parasites that express proteins expressed on the human version of the malaria parasite. The research was funded by the PATH’s Malaria Vaccine Initiative and the Medical Research Council (MRC), including researchers at Imperial’s MRC Centre for Outbreak Analysis and Modelling.
Lead researcher Dr Andrew Blagborough, from the Department of Life Sciences at Imperial, said: “This is the first direct evidence than combining vaccines of different types significantly improves their efficacy in terms of reducing malarial burden.
“Reaching a potential 91% reduction in cases would have a huge impact on public health because the vaccines could be effective in areas where malaria is more prevalent.”
Two types of vaccines
Malaria is caused by a group of parasites that have a complex life cycle, spending time in the mosquito midgut and salivary glands, in the human liver, and circulating in human blood, where they cause the disease.
The team tested two types of vaccines: those that prevent mosquitoes from transferring the parasites, called transmission-blocking vaccines (TBVs), and those that prevent the parasite from infecting the liver, termed pre-erythrocytic vaccines (PEVs).
RTS,S is the world’s first PEV malaria vaccine that has been shown to provide partial protection against malaria in young children by blocking infection of the liver. However, its maximum efficacy is under 50% (i.e. it reduces cases by around 50%).
There are currently several types of transmission-blocking vaccines in early trials, which are thought to reduce the number of parasites in the mosquito salivary glands. Their efficacy typically ranges from around 50-95%.
It has been assumed that combining these vaccines would increase their efficacy, but it has never been tested until now. The team found that when a partially effective PEV was combined with the most effective transmission-blocking vaccine, the efficacy was around 91%.
The team also found that combining any of the two types of vaccines improved efficacy of the mixture more than might be expected from the single efficacy of each vaccine separately.
Working towards elimination
Dr Morven Roberts, Programme Manager for parasites and neglected tropical diseases at the MRC, said: “While these findings are in the preliminary stages, they’re valuable as they shed light on optimising strategies for preventing malaria. Learning that combining vaccines can dramatically boost efficacy in mice provides another potential tactic for controlling this disease. This is timely research as global health officials work towards WHO targets to eliminate malaria by 2030.”
The team will next study how combined vaccines could work in more complex situations. Dr Blagborough said: “In the real world, the vaccine coverage we can achieve– how many people we can give it to – is important, as are the local levels of transmission, and how prevalent malaria currently is in that area.
“We plan to use a combination of rodent experiments and computer modelling to help us estimate effectiveness requirements for future vaccines.”
The efficacy of current lead malaria vaccines is known to reduce over time after vaccines are administered, so the team will also investigate how combined vaccines perform in the long term.
The Latest on: Malaria
via Google News
The Latest on: Malaria
- Monkey malaria breakthrough offers possible cure for relapsing malariaon August 15, 2019 at 8:15 am
A breakthrough in monkey malaria research could help scientists diagnose and treat a relapsing form of human malaria. A breakthrough in monkey malaria research by two University of Otago scientists ...
- Monkey malaria breakthrough offers cure for relapsing malariaon August 15, 2019 at 5:40 am
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria. Malaria is a mosquito-borne infectious ...
- Numerical Modeling of the Dynamics of Malaria Transmission in a Highly Endemic Region of Indiaon August 15, 2019 at 2:39 am
Using a dynamical model (VECTRI) for malaria transmission that accounts for the influence of population and climatic conditions, malaria transmission dynamics is investigated for a highly endemic ...
- RTS,S vaccine could favor the acquisition of natural immunity against malariaon August 14, 2019 at 2:56 pm
The RTS,S malaria vaccine could enhance the production of protective antibodies upon subsequent parasite infection, according to a study led by the Barcelona Institute for Global Health (ISGlobal ...
- Uganda says malaria prevalence surges, cites climate change and refugeeson August 14, 2019 at 8:26 am
The ministry of health said in a statement its data showed malaria cases recorded in June this year jumped 40% to 1.4 million from the same month last year KAMPALA, Aug 14 (Reuters) - Uganda said ...
- Burundian YouTube Child Star's Death Highlights Malaria Epidemicon August 13, 2019 at 11:54 pm
The death of six-year-old YouTube star Darcy Irakoze, popularly known as Kacaman, has prompted a wave of tributes and sparked debate about malaria in Burundi. The UN has said that the disease has ...
- Burundian YouTube child star's death spotlights malaria epidemicon August 13, 2019 at 8:58 am
A woman comforts her son, who is suffering from malaria, as they wait for treatment at a Medecins Sans Frontieres (MSF) run clinic in the village of Likuangole, in Boma state, east South Sudan ...
- Rwanda to Start Using Drones in Malaria Fighton August 13, 2019 at 4:09 am
In order to generate African solutions to African challenges, researchers on the continent are being offered grants to come up with new drugs to fight malaria, tuberculosis and ... Read more ...
- Mosquito 'spit glands' hold key to curbing malaria, study showson August 12, 2019 at 11:35 am
Mosquitoes can harbor thousands of malaria-causing parasites in their bodies, yet while slurping blood from a victim, they transmit just a tiny fraction of them. In an effort to define precisely the ...
via Bing News